The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Malova I.O.

GBOU VPO "Irkutskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdravsotsrazvitiia Rossii

Primak N.B.

GBOU VPO "Irkutskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdravsotsrazvitiia Rossii

Afanas'eva I.G.

GBOU VPO "Irkutskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdravsotsrazvitiia Rossii

Zinov'eva T.K.

GBOU VPO "Irkutskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdravsotsrazvitiia Rossii

Acute vulvovaginal candidiasis: a new solution to the old problem

Authors:

Malova I.O., Primak N.B., Afanas'eva I.G., Zinov'eva T.K.

More about the authors

Read: 1270 times


To cite this article:

Malova IO, Primak NB, Afanas'eva IG, Zinov'eva TK. Acute vulvovaginal candidiasis: a new solution to the old problem. Russian Journal of Clinical Dermatology and Venereology. 2012;10(4):53‑57. (In Russ.)

References:

  1. Savicheva A.M., Kisina V.I., Sokolovskii E.V. i dr. Kandidoznyi vul'vovaginit: metodicheskie rekomendatsii dlya vrachei. SPb: Izd-vo N-L 2009; 88.
  2. Karapetyan T.E., Naskhletashvili I.V., Tyutyunnik V.L. Vul'vovaginal'nyi kandidoz: sovremennyi vzglyad na problemu. Rus med zhurn 2011; 1: 64-68.
  3. Tyutyunnik V.L. Vul'vovaginal'nyi kandidoz: sovremennye predstavleniya i osnovnye printsipy lecheniya. Med vestn 2005; 23: 330: 14-15.
  4. Sergeev A.Yu. Kandidoz. Priroda infektsii, mekhanizmy agressii i zashchity, laboratornaya diagnostika, klinika i lechenie. Pod red. A.Yu. Sergeeva, Yu.V. Sergeeva. M: Triada- X 2000; 472.
  5. Ankirskaya A.S., Murav'eva V.V., Mironova T.G. i dr. Genital'nyi kandidoz v strukture opportunisticheskikh infektsii vlagalishcha. Printsipy laboratornoi diagnostiki i znachenie monitoringa chuvstvitel'nosti gribov k antimikotikam. Akush i ginekol 2009;5:31-37.
  6. Bairamova G.R. Khronicheskii retsidiviruyushchii vul'vovaginal'nyi kandidoz: etiopatogenez, diagnostika, lechenie. Vopr ginekol akush i perinatol 2007; 6: 3: 82-86.
  7. Dermatovenerologiya. Klinicheskie rekomendatsii. Pod red. A.A. Kubanovoi. M: DEKS-Press 2010; 428.
  8. Workowski K.A., Berman S. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59: RR-12:1-110.
  9. Sherrard J., Donders G., White D., Jensen J.S.; European IUSTI. European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011. Int J STD AIDS 2011; 22: 8: 421-429.
  10. Veronese M., Barzafhi D., Bertoncini A. Antifungal activity of Fenticonazole in experimental dermatomycosis and candidiasis. Arznneim Forsch Drug Res 1981; 13: 2137-2139.
  11. Veronese M., Salvaterra M., Bertoncini A. Fenticonazole, a new imidazole derivative with antibacterial and antifungal activity. "In vitro" study. Arznneim Forsch Drug Res 1981; 13: 2133-2137.
  12. Veronese M., Barzaghi D., Bertoncini A., Cornelli U. Fenticonazole: a new antifungal imidazole derivative in vitro and in vivo antimycotic activity. Mycosen 1984; 27: 4: 194-202.
  13. Costa A.L. In vitro antimycotic activity of Fenticonazole. Mycosen 1982; 25: 7-52.
  14. Cusumano V., Costa A.L., Veronese M. Evaluation of the antifungal activity of Fenticonazole on strains of Candida albicans on cellular lines. Mycosen 1985; 28: 238.
  15. Angiolella L., De Bernardis F., Bromuro C. et al. The effect of antimycotics on secretory acid proteinase of Candida albicans. J Chemother 1990; 2: 1: 55-61.
  16. Brewster E., Preti P.M., Ruffmann R., Studd J. Effect of fenticonazole in vaginal candidiasis: a double-blind clinical trial versus clotrimazole. J Int Med Res 1986; 14: 6: 306-310.
  17. Studd J.W.W., Dooley M.M., Welch C.C. et al. Comparative clinical trial of Fenticonazole ovule (600 mg) versus clotrimazole vaginal tablet (500 mg) in the treatment of symptomatic vaginal candidiasis. Curr Med Res Opin 1980; 11: 8: 477-484.
  18. Wiest W., Azzollini E., Ruffmann R. Comparison of single administration with an ovule of 600 mg Fenticonazole versus a 500 mg clotrimazole vaginal pessary in the treatment of vaginal candidiasis. J Int Med Res 1989; 17: 4: 369-372.
  19. Schneider D., Caspi E., Arieli S. et al. Fenticonazole is in treatment of vaginal candidosis. Advanc Ther 1990; 7: 6: 35-41.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.